Pyxis Oncology Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results March 24, 2026
Immunitas Therapeutics to Present Clinical Data Supporting Monotherapy and Combination Treatment Potential of IMT-009 at the AACR 2026 Annual Meeting March 18, 2026
Xaira Therapeutics Launches X-Cell, Its First Virtual Cell Model, Trained on the Largest-Ever Genome-Wide Perturbation Dataset, X-Atlas/Pisces March 18, 2026
Evommune Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Highlights March 6, 2026
BBOT Reports Fourth Quarter and Full Year 2025 Financial Results and Update on Corporate Progress March 6, 2026
TScan Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update March 5, 2026
